A combination of chemotherapy and chimeric antigen receptor (CAR) T cells designed to target the protein HER2 was found to be safe in patients with advanced HER2-positive sarcoma.
from Medindia Health News https://ift.tt/2TKBfHT
Monday, 1 April 2019
Antitumor Activity of HER2-targeted CAR T-cell Therapy in Patients With Sarcoma
A combination of chemotherapy and chimeric antigen receptor (CAR) T cells designed to target the protein HER2 was found to be safe in patients with advanced HER2-positive sarcoma.
from Medindia Health News https://ift.tt/2TKBfHT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment